Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
That anti-TNF therapy and rituximab therapy are equally effective in treating patients with
rheumatoid arthritis who meet the eligibility criteria for biologic therapy in the British
Society for Rheumatology guidelines, and have not previously been exposed to biologic
therapy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Glasgow
Collaborators:
Arthritis Research UK NHS Borders NHS Fife NHS Grampian NHS Lothian NHS Tayside